Peptide Therapeutics Market Size to Hit USD 91.25 Bn by 2031 | TMR Study
14 avr. 2023 15h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, April 15, 2023 (GLOBE NEWSWIRE) -- The worldwide market for peptide therapeutics is forecasted to augment at a CAGR of 8.8% from 2022 to 2031. According to...
MBX Biosciences to Participate in the SVB Securities Global Biopharma Conference
24 janv. 2023 08h00 HE
|
MBX Biosciences, Inc.
CARMEL, Ind., Jan. 24, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...
MBX Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
05 janv. 2023 08h00 HE
|
MBX Biosciences, Inc.
CARMEL, Ind., Jan. 05, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...
MBX Biosciences Closes $115 Million Series B Financing to Advance Development of Endocrine Disease Programs
14 nov. 2022 08h00 HE
|
MBX Biosciences, Inc.
CARMEL, Ind., Nov. 14, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...
Zealand Pharma Announces Financial Results for the First Nine Months of 2022
10 nov. 2022 09h00 HE
|
Zealand Pharma
Company announcement No. 51 / 2022 Zealand Pharma Announces Financial Results for the First Nine Months of 2022 Copenhagen, Denmark November 10, 2022 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no....
MBX Biosciences Advances Phase 1 Clinical Trial of Long-Acting Parathyroid Hormone Peptide Prodrug, MBX 2109
05 oct. 2022 09h00 HE
|
MBX Biosciences, Inc.
CARMEL, Ind., Oct. 05, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...
Peptide Therapeutics Market Expanding at an Impressive CAGR of 11% over the period of 2022 to 2025 | Future Market Insights, Inc.
06 sept. 2022 07h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The global peptide therapeutics market is projected to reach a valuation of US$ 47 Bn in 2025, with sales growing at a prolific CAGR of 11% from 2022...
Peptide Therapeutics Market is estimated to be US$ 66.18 billion by 2030 with a CAGR of 6.10% during the forecast period - By PMI
04 juil. 2022 09h43 HE
|
PMI
Covina, July 04, 2022 (GLOBE NEWSWIRE) -- The joining of two or more amino acid monomers via amide bonds forms peptides. The size of a peptide is what separates it from a protein. Peptides are...
MBX Biosciences Appoints Richard B. Bartram as Chief Financial Officer
11 avr. 2022 07h30 HE
|
MBX Biosciences, Inc.
CARMEL, Ind., April 11, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing peptide therapeutics with a focus on the treatment of endocrine...
The peptide therapeutics contract API manufacturing market is anticipated to grow at an annualized rate of 13.6%, claims Roots Analysis
07 avr. 2022 09h30 HE
|
Roots Analysis
London, April 07, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Peptide Therapeutics: Contract API Manufacturing Market (2nd Edition), 2022-2035” report to its list of...